Literature DB >> 18991597

Insights into the regulation of renal hemodynamic function in diabetic mellitus.

David Z I Cherney1, James W Scholey, Judith A Miller.   

Abstract

Diabetes mellitus (DM) is characterized by renal hemodynamic changes which have been purported to contribute to the development of nephropathy. In this review we have focused on the major renal hemodynamic factors that may be associated with glomerular hyperfiltration. Recent animal and human studies have demonstrated that renal hemodynamic alterations occur very early in the natural history of DM. Most of the literature related to renal hemodynamic functional changes in type 1 DM has focused on major neurohormonal influences, such as the renin angiotensin system, cyclooxygenase-related pathways, the nitric oxide system, the autonomic nervous system and hyperglycemia. In addition, gender may have important modulatory effects on some of these putative pathways that have been implicated in the development of alterations in renal hemodynamic function related to DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991597     DOI: 10.2174/157339908786241151

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  24 in total

1.  Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.

Authors:  Mark E Molitch; Xiaoyu Gao; Ionut Bebu; Ian H de Boer; John Lachin; Andrew Paterson; Bruce Perkins; Amy K Saenger; Michael Steffes; Bernard Zinman
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-23       Impact factor: 8.237

Review 2.  Obesity, metabolic syndrome and diabetic nephropathy.

Authors:  Christine Maric; John E Hall
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

Review 3.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

4.  The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.

Authors:  R Har; J W Scholey; D Daneman; F H Mahmud; R Dekker; V Lai; Y Elia; M L Fritzler; E B Sochett; H N Reich; D Z I Cherney
Journal:  Diabetologia       Date:  2013-02-15       Impact factor: 10.122

5.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

6.  Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

Authors:  Srinivasan Beddhu; Tom Greene; Robert Boucher; William C Cushman; Guo Wei; Gregory Stoddard; Joachim H Ix; Michel Chonchol; Holly Kramer; Alfred K Cheung; Paul L Kimmel; Paul K Whelton; Glenn M Chertow
Journal:  Lancet Diabetes Endocrinol       Date:  2018-04-21       Impact factor: 32.069

7.  Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Julie A Lovshin; Yuliya Lytvyn; Leif E Lovblom; Alexandra Katz; Geneviève Boulet; Petter Bjornstad; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Hillary A Keenan; Narinder Paul; Vera Bril; David T Wong; Kylen D McReelis; Michael H Brent; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-12-06       Impact factor: 19.112

8.  Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Julie A Lovshin; Genevieve Boulet; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Leif E Lovblom; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Andrew Advani; Etienne Sochett; Bruce A Perkins; David Z I Cherney
Journal:  Am J Kidney Dis       Date:  2019-02-22       Impact factor: 8.860

9.  The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.

Authors:  David Z I Cherney; Heather N Reich; James W Scholey; Denis Daneman; Farid H Mahmud; Ronnie L H Har; Etienne B Sochett
Journal:  Diabetologia       Date:  2013-07-28       Impact factor: 10.122

Review 10.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.